DOI QR코드

DOI QR Code

Prolonged Gene Expression Following Erythrocyte-Mediated Delivery of TRAIL Plasmid DNA

혈구세포 수송체로 투여된 트레일 유전자의 혈중 발현 지속 효과

  • Published : 2003.12.20

Abstract

Tumor necrosis facto-related apoptosis-inducing ligand (TRAIL) is a recently identified member of the tumor necrosis factor cytokine superfamily. TRAIL has been shown to induce apoptosis in a number of tumor cells whereas cells from most of normal tissues are highly resistant to TRAIL-induced apoptosis. These observations have raised considerable interest in the use of TRAIL in tumor therapy. In this study we report the biodistribution fates and serum expression pattern of plasmid DNA encoding TRAIL (pTRAIL) delivered in erythrocyte ghosts (EG). pTRAIL was loaded into EG by electroportion in a hypotonic medium The mRNA expression of pTRAIL was prolonged following delivery in EG-encapsulated forms. EG containing pTRAIL showed significant levels of mRNA expression in the blood over 9 days. The organ expression patterns of pTRAIL delivered via EG, however, did not significantly differ from those of naked pTRAIL, indicating that the expression-enhancing effect of EG containing pTRAIL was localized to the blood. These results suggest that pTRAIL-loaded EG might be of potential use in the treatment of hematological diseases such as TRAIL-sensitive leukemia.

References

  1. A.E. Tollefson, K. Toth, K. Doronin, M. Kuppuswamy, O. A Doronina, D.L. Lichtenstein, T.W. Hermiston, C.A. Smith and W.S. Wold. Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins. J. Virol., 75, 8875-8887 (2001) https://doi.org/10.1128/JVI.75.19.8875-8887.2001
  2. Q. Chen, S. Ray, M.A. Hussein, G. Srkalovic and A. Almasan. Role of Apo2L/TRAlL and Bcl-2-family proteins in apoptosis of multiple myeloma. Leuk. Lymphoma, 44, 1209-1214 (2003) https://doi.org/10.1080/1042819031000068052
  3. A.K. Simon, O. Williams, J. Mongkolsapaya, B. Jin, Xu XN, H. Walczak and G.R. Screaton. Tumor necrosis factorrelated apoptosis-inducing ligand in T cell development: sensitivity of human thymocytes. Proc. Natl. Acad. Sci. U S A., 98, 5158-5163 (2001) https://doi.org/10.1073/pnas.091100398
  4. T. Naka, K. Sugamura, B.L. Hylander, M.B. Widmer, Y.M. Rustum and E.A. Repasky. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with chemotherapeutic agents on patients' colon tumors grown in SCID mice. Cancer Res., 62, 5800-5806 (2002)
  5. R.W. Malone, M.A. Hickman, K. Lehmann-Bruinsma, T.R. Sih, R. Walzem, D.M. Carlson and J.S. Powell. Dexamethasone enhancement of gene expression after direct hepatic DNA injection. J. Biol. Chem., 269, 29903-29907 (1994)
  6. M.A. Hickman, R.W. Malone, K. Lehmann-Bruinsma, T.R. Sih, D. Knoell, F.C. Szoka, R. Walzem, D.M. Carlson and J.S. Powell. Gene expression following direct injection of DNA into liver. Hum. Gene Ther., 5,1477-1483 (1994) https://doi.org/10.1089/hum.1994.5.12-1477
  7. G.Y Wu and C.H. Wu. Receptor-mediated gene delivery and expression in vivo. J. Bioi. Chem., 263, 14621-14624 (1988)
  8. Y.K. Oh, D. Suh, J.M. Kim, H.G. Choi, K. Shin and J.J. Ko. Polyethylenimine-mediated cellular uptake, nucleus trafficking and expression of cytokine plasmid DNA. Gene Ther. 9, 1627-1632 (2002) https://doi.org/10.1038/sj.gt.3301735
  9. S.F. Alino, J. Crespo, M. Bobadilla, M. Lejarreta, C. Blaya and A Crespo. Expression of human alpha 1-antitrypsin in mouse after in vivo gene transfer to hepatocytes by small liposomes. Biochem. Biophys. Res. Commun., 204, 1023-1030 (1994) https://doi.org/10.1006/bbrc.1994.2565
  10. T. Hara, Y. Aramaki, S. Takada, K. Koike, and S. Tsuchiya. Receptor-mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes. Gene Ther., 2, 784-788 (1995)
  11. R.K. Scheule, St J.A. George, R.G. Bagley, J. Marshall, J.M. Kaplan, G.Y. Akita, K.X. Wang, E.R. Lee, D.J. Harris, C. Jiang, N.S. Yew, A.E. Smith and S.H. Cheng. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum. Gene Ther., 8, 689-707 (1997) https://doi.org/10.1089/hum.1997.8.6-689
  12. M. Magnani, L. Rossi, A. Fatemale, M. Bianchi, A. Antonelli, R. Crinelli and L. Chiaranti. Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides. Gene Then, 9, 749-751 (2002) https://doi.org/10.1038/sj.gt.3301758
  13. M. Magnani, A Casabianca, A Fratemale, G. Brandi, S. Gessani, R Williams, M. Giovine, G. Damonte, A. De Flora and U. Benatti. Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection. Proc. Natl. Acad. Sci. USA., 93, 4403-4408 (1996) https://doi.org/10.1073/pnas.93.9.4403
  14. J.R. DeLoach, and R. Droleskey. Preparation of ovine carrier erythrocytes: their action and survival. Camp. Biochem. Physiol. A., 843, 441-445 (1986)
  15. 변향민, 박상은, 김정목, 고정재, 오유경. 플라스미드 유전자 함유 혈구 세포 입자의 제조. 한국약제학회지, 32, 181-184 (2002)
  16. M. Plasilova, J. Zivny, J. Jelinek, R. Neuwirtova, J. Cermak, E. Necas, L. Andera and T. Stopka. TRAIL (Apo2L) suppresses growth of primary human leukemia and myelodysplasia progenitors. Leukemia, 16, 67-73 (2002) https://doi.org/10.1038/sj.leu.2402338